PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070231304A1
SERIAL NO

11668981

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the identification of various prognostic factors that predict response in patients with hyperproliferative disease such as cancer to gene therapy, and their use in methods of treating such patients with an anti-hyperproliferative disease gene therapy. Also described are methods of treatment for Li Fraumeni syndrome, and for assessing anti-cancer gene therapy using PET scans.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTROGEN THERAPEUTICS INC301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chada, Sunil Missouri City, TX 36 343
Cvitkovic, Esteban Le Kremlin-Bicetre Cedex, FR 3 6
Menander, Kerstin Bellaire, TX 7 71
Sobol, Robert E Rancho Sante Fe, CA 61 1401
Zumstein, Louis Del Mar, CA 2 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation